Abiopharma

🔍 Alvarez-Demalde Francisco (Director)

Company: Globant S.A. (GLOB)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 945 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,526.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Quarterly grant to non-executive directors of restricted stock units (RSUs), which settle on a one-for-one basis into shares of the issuer's common stock.
• F2: Includes 3,141 restricted stock units (RSUs), which settle on a one-for-one basis into shares of the issuer's common stock. Of these RSUs, 580 will vest on December 1, 2026; 773 will vest on March 1, 2027, 843 will vest on June 1, 2027 and 945 will vest on September 1, 2027.